colistimethate sodium
colistimethate sodium is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
Aerosolized and Intravenous Colistin in Healthy Adults
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
Clinical Trials (9)
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
Aerosolized and Intravenous Colistin in Healthy Adults
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)
Phase I Study of Colistin Methanesulfonate Sodium
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9